An	O
Accessible	O
and	O
Pragmatic	B:C0887965
Experimental	I:C0887965
Model	I:C0887965
of	O
Nonalcoholic	B:C0400966
Fatty	I:C0400966
Liver	I:C0400966
Disease	I:C0400966
.	O

There	O
is	O
no	O
convenient	O
cheap	O
pragmatic	B:C0887965
experimental	I:C0887965
model	I:C0887965
for	O
Nonalcoholic	B:C0400966
Fatty	I:C0400966
Liver	I:C0400966
Disease	I:C0400966
(	O
Nonalcoholic	B:C0400966
Fatty	I:C0400966
Liver	I:C0400966
Disease	I:C0400966
)	O
/	O
Nonalcoholic	B:C3241937
Steatohepatitis	I:C3241937
(	O
Nonalcoholic	B:C3241937
Steatohepatitis	I:C3241937
)	O
.	O

Our	O
objective	O
was	O
to	O
create	O
a	O
pragmatic	B:C0887965
model	I:C0887965
of	O
Nonalcoholic	B:C0400966
Fatty	I:C0400966
Liver	I:C0400966
Disease	I:C0400966
/	O
Nonalcoholic	B:C3241937
Steatohepatitis	I:C3241937
.	O

Sprague	B:C0034715
-	I:C0034715
Dawley	I:C0034715
rats	I:C0034715
were	O
fed	O
a	O
high	B:C0521974
-	I:C0521974
fat	I:C0521974
,	O
high	B:C1445913
sugar	I:C1445913
homemade	I:C1445913
diet	I:C1445913
ad	O
libitum	O
for	O
seven	O
weeks	O
.	O

The	O
high	B:C0521974
-	I:C0521974
fat	I:C0521974
,	O
high	B:C1445913
sugar	I:C1445913
diet	I:C1445913
included	O
59	O
%	O
of	O
energy	O
derived	O
from	O
fat	B:C0012171
,	O
30	O
%	O
from	O
carbohydrates	B:C0453802
,	O
and	O
11	O
%	O
from	O
protein	B:C0453858
.	O

Serum	B:C0583334
levels	I:C0583334
of	I:C0583334
fasting	I:C0583334
glucose	I:C0583334
,	O
triglyceride	B:C0542495
,	O
cholesterol	B:C1445957
,	O
liver	B:C0428321
enzymes	I:C0428321
,	O
insulin	B:C0428357
,	O
and	O
hepatic	B:C0205054
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
(	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
)	O
gene	B:C0017262
expression	I:C0017262
were	O
determined	O
.	O

Hepatic	B:C0205054
histology	B:C0344441
was	O
examined	O
by	O
H&E	B:C0523207
stain	I:C0523207
.	O

Rats	B:C0034721
fed	O
the	O
high	B:C0521974
-	I:C0521974
fat	I:C0521974
,	O
high	B:C1445913
sugar	I:C1445913
diet	I:C1445913
developed	O
hepatic	B:C0015695
steatosis	I:C0015695
,	O
and	O
a	O
moderate	B:C0522568
inflammation	I:C0522568
,	O
which	O
was	O
associated	O
with	O
increased	B:C0857093
serum	I:C0857093
levels	I:C0857093
of	I:C0857093
liver	I:C0857093
enzymes	I:C0857093
,	O
glucose	B:C0583332
,	O
insulin	B:C1261415
,	O
triglyceride	B:C1287372
,	O
cholesterol	B:C1287371
,	O
and	O
hepatic	B:C0205054
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-	I:C1456820
alpha	I:C1456820
gene	B:C0017262
expression	I:C0017262
.	O

This	O
rat	B:C0034721
model	B:C0887965
resembles	O
the	O
key	O
features	O
of	O
human	B:C0086418
Nonalcoholic	B:C0400966
Fatty	I:C0400966
Liver	I:C0400966
Disease	I:C0400966
/	O
Nonalcoholic	B:C3241937
Steatohepatitis	I:C3241937
and	O
provides	O
a	O
simple	O
pragmatic	B:C0887965
experimental	I:C0887965
model	I:C0887965
for	O
elucidating	O
the	O
disease	O
prevention	O
and	O
treatment	B:C0087111
.	O

